PFIZER INC Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31)
PFIZER INC (PFE) had Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) of $1.47 billion as of 2013-03-31, per its 10-Q filed 2013-05-10.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:HeldToMaturitySecuritiesDebtMaturitiesNetCarryingAmount · last filed 2013-05-10
- 2013-03-31: Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) $1.47B.
- 2012-12-31: Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) $1.51B.
- 2012-09-30: Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) $3.03B.
- 2012-07-01: Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) $1.59B.
| Period end | Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) | Held-to-maturity Securities, Debt Maturities, Net Carrying Amount (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2013-03-31 | $1.47B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $1.51B 10-Q · filed 2013-05-10 | |
| 2012-09-30 | $3.03B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $1.59B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $1.59B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $1.59B 10-K · filed 2013-02-28 | $1.16B 10-K · filed 2012-02-28 |
| 2011-10-02 | $1.20B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $781.00M 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $848.00M 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $1.18B 10-K · filed 2012-02-28 | |
| 2010-10-03 | $1.80B 10-Q · filed 2010-11-12 | |
| 2010-07-04 | $1.35B 10-Q · filed 2010-08-12 | |
| 2009-12-31 | $812.00M 10-K · filed 2011-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |